4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001827672-21-000002
President and CEO sold 5,833 shares at an average $25.25 ($147,301)
From the SEC's structured data for this filing
Trades in this filing
Azamian Bobak R. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-01 | Sale : show line 1 in the form | −5,733 | $25.23 | $144,661 | 1,221,705 | I |
| 2021-09-01 | Sale : show line 2 in the form | −100 | $26.40 | $2,640 | 1,221,605 | I |
| Open-market sales · 5,833 sh · avg $25.25 · $147,301 | ||||||
Loading xslF345X03/wf-form4_163070587277035.xml…